Cullinan Therapeutics (CGEM) Selling, General & Administrative (2020 - 2026)
Cullinan Therapeutics' Selling, General & Administrative was $12.82 million in Q2 2026, down 13.2% from $14.77 million a year earlier but up 10.7% from the prior quarter.
Powered by 
Analysis
Cullinan Therapeutics (CGEM) Selling, General & Administrative (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Cullinan Therapeutics' Selling, General & Administrative was $50.33 million through Jun 30, 2026, down 10.5% year-over-year; for FY2025, it was $54.25 million, up 0.4% from FY2024.
- Selling, General & Administrative has now increased for five consecutive years, with a five-year compound annual growth rate of 25.9% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $54.02 million in FY2024 (+27.1%), $42.49 million in FY2023 (+5.7%), $40.19 million in FY2022 (+37.9%) and $29.15 million in FY2021 (+70.2%).
- Quarterly Selling, General & Administrative has moved between $5.7 million (Q3 2021) and $14.77 million (Q2 2025) over five years.
- Compared with a year earlier, Selling, General & Administrative has declined for three straight quarters, with growth averaging 4.3% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2021 (growth of 259.1%); the worst was Q4 2022 (a decline of 16.2%).
- Per Business Quant data, CGEM's Selling, General & Administrative in the three quarters before Q2 2026 was $11.57 million (Q1 2026), $12.31 million (Q4 2025) and $13.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Cullinan Therapeutics | 987.71 Mn | 987.71 Mn | - | 12.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.82 Mn |
| Mar 31, 2026 | 11.57 Mn |
| Dec 31, 2025 | 12.31 Mn |
| Sep 30, 2025 | 13.63 Mn |
| Jun 30, 2025 | 14.77 Mn |
| Mar 31, 2025 | 13.54 Mn |
| Dec 31, 2024 | 14.56 Mn |
| Sep 30, 2024 | 13.35 Mn |
| Jun 30, 2024 | 13.77 Mn |
| Mar 31, 2024 | 12.34 Mn |
| Dec 31, 2023 | 10.64 Mn |
| Sep 30, 2023 | 10.98 Mn |
| Jun 30, 2023 | 10.21 Mn |
| Mar 31, 2023 | 10.66 Mn |
| Dec 31, 2022 | 11.29 Mn |
| Sep 30, 2022 | 10.09 Mn |
| Jun 30, 2022 | 10.70 Mn |
| Mar 31, 2022 | 8.12 Mn |
| Dec 31, 2021 | 13.47 Mn |
| Sep 30, 2021 | 5.70 Mn |
API Access
Cullinan Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CGEM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "CGEM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CGEM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();